In a major shake-up, the Trump administration has announced a drastic restructuring of the U.S. Department of Health and Human Services (HHS), slashing 20,000 jobs in a bid to streamline operations and reduce federal spending.
Massive Workforce Reduction
The workforce at HHS will shrink from 82,000 to 62,000 employees. Many cuts stem from early retirement offers and voluntary separation programs under the administration’s Fork in the Road initiative, with an additional 10,000 job losses to follow. The number of divisions within HHS will also be reduced from 28 to 15, aiming to curb bureaucratic inefficiencies.
HHS Secretary Robert F. Kennedy Jr. defended the move, stating it would focus the agency on reversing the chronic disease epidemic. “We are aligning the department with its core mission, ensuring better health outcomes at a lower cost to taxpayers,” Kennedy said.
Introducing the Administration for a Healthy America
A key part of the restructuring is the formation of the Administration for a Healthy America (AHA). The new agency will consolidate various existing programs to enhance chronic disease prevention and primary care initiatives. It will prioritize maternal and child health, mental health services, and HIV/AIDS programs.
Impact Across Key Agencies
The cuts will hit multiple HHS agencies. The Food and Drug Administration (FDA) will lose 3,500 employees, while the Centers for Disease Control and Prevention (CDC) will cut 2,400 jobs. The National Institutes of Health (NIH) will reduce its workforce by 1,200, and the Centers for Medicare & Medicaid Services (CMS) will see 300 layoffs. HHS assures that core functions like drug safety reviews and food inspections will not be impacted.
Budgetary Goals and Fiscal Impact
HHS estimates the job cuts will result in $1.8 billion in annual savings. The department currently manages a budget nearing $2 trillion, with most funds allocated to Medicare and Medicaid. The cuts align with President Trump’s broader initiative to reduce government size, championed by Elon Musk’s Department of Government Efficiency (DOGE).
Divisive Reactions from Lawmakers
The announcement has sparked a range of reactions. Senator Angela Alsobrooks (D-Md.) criticized the decision, warning it would endanger public health. “These mass layoffs will cost lives,” she said.
On the other hand, Senator Bill Cassidy (R-La.) said he hoped the restructuring would lead to more effective drug approvals and better Medicare management.
Health policy experts like Larry Levitt from KFF voiced concern that the reductions could compromise oversight efforts, leading to fraud and mismanagement.
Kennedy Defends the Overhaul
In a public address, Kennedy described HHS as inefficient and claimed that over half of its employees failed to report to work. He accused divisions within HHS of fostering corruption by selling patient data, though no evidence was provided to support these claims.
Fear and Uncertainty Among Health Agencies
NIH employees described a climate of anxiety, fearing the layoffs would harm critical research programs. Former NIH director Jeremy Berg called the cuts “yet another assault on the NIH’s ability to fulfill its mission.”
Structural Changes to ASPR
Further controversy surrounds the relocation of the Administration for Strategic Preparedness and Response (ASPR) under the CDC. ASPR, which coordinates emergency medical responses, previously operated independently. Critics, including former ASPR head Dawn O’Connell, argue that this change could slow response times during emergencies.
Union and Advocacy Pushback
The National Treasury Employees Union (NTEU) condemned the layoffs, with its president Doreen Greenwald calling them “devastating.” Additionally, Dr. Georges Benjamin from the American Public Health Association warned that the cuts would increase mortality rates, inflate healthcare costs, and weaken the economy.
Employees will learn their employment status on Friday, with layoffs set to take effect in May. Further cuts may follow as incoming NIH director Dr. Jay Bhattacharya conducts his own review.
The future of HHS remains uncertain, with public health advocates and lawmakers continuing to debate the long-term implications of the restructuring. As the changes roll out, the administration will face ongoing scrutiny over its commitment to safeguarding public health.
